Q&A: As RSV vaccine approvals loom, regulators need to devise vaccination strategies
Sachiko Ozawa, a health economist, discusses nuances of vaccine launch strategies, as PDUFA dates for two RSV vaccines for older adults near the horizon.
Sachiko Ozawa, a health economist, discusses nuances of vaccine launch strategies, as PDUFA dates for two RSV vaccines for older adults near the horizon.